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Background: Diabetes Prevention Programs (DPPs) comprising intensive lifestyle 
interventions may delay or even prevent the onset of type 2 diabetes in people with pre-
diabetes. However, engagement with DPPs is variable with session times and transportation 
being reported amongst barriers; this may be addressed by community pharmacy (CP) 
involvement given its recognition for accessibility. 
 
Objectives:  To explore factors influencing engagement with the National Health Service 
(NHS) DPP and the role of CP in diabetes prevention.  
 
Methods:  Nine hundred and sixty-two questionnaires were posted to people with pre-
diabetes identified from five general practices in Norfolk, England between November 2017 
and May 2018. Follow-up semi-structured interviews (n=10) and a focus group (n=6) were 
conducted with a sample of questionnaire respondents. Questionnaire data were analysed 
quantitatively using SPSS and qualitative data analysed inductively using thematic analysis. 
Themes relating to engagement and the role of CP in pre-diabetes were further analysed 
using the COM-B model of behaviour change.  
 
Results: A total of 181 (18.8%) questionnaire responses were received, a quarter of whom 
reported to have either dropped out or declined attending the national DPP. DPP engagers 
were more likely to report the program location and session times as convenient. Community 
pharmacy was perceived as an acceptable setting for delivering diabetes prevention 
services (DPS) and a preferable alternative for regular pharmacy users and people with work 
and social commitments. Participants felt that opportunity to engage with CP DPS could be 
enhanced by its accessibility and flexibility in making appointments. Knowledge about the 
DPS provided in CP and previous experience with CP services were central influences of 
capability and motivation to engage respectively.  
 
Conclusions: This research outlines factors that could influence engagement with 
community pharmacy-based DPS and provides evidence to inform intervention 
development. Further research would be required to determine the feasibility and cost-










In England, an estimated 2.7 million people are living with type 2 diabetes 1 for which the 
National Health Service (NHS) incurs an annual spend of approximately £8.8 billion (10% of 
the total budget) 2. Additionally, five million people in England are estimated to have ‘pre-
diabetes’, a term used to denote blood glucose levels above normal range but not high enough 
for diagnosis of type 2 diabetes 3 4. The risk of developing type 2 diabetes depends on multiple 
risk factors, of which obesity is most significant 5.  
 
Central to the approach for the prevention of type 2 diabetes is the promotion of healthy diet 
and exercise to reduce obesity 6. Evidence suggests that if individuals with pre-diabetes are 
identified and intensive lifestyle interventions are implemented early, the onset of type 2 
diabetes may be delayed or even prevented 7-15. In England, the NHS Diabetes Prevention 
Program (NHS DPP) has been implemented in light of this evidence 15. The DPP is a 9-
month intervention which identifies people with pre-diabetes, primarily through retrospective 
screening of general practice databases, and refers them onto a behavioural change 
intervention to reduce their risk of developing type 2 diabetes 16. The intervention, consisting 
of at least 16 hours contact time spread across a minimum of 13 sessions, is delivered 
predominantly by face to face group sessions with a maximum of 20 people in each group17. 
The sessions last between 1-2 hours and deliver education (type 2 diabetes and its risk 
factors, weight loss, dietary and physical activity), provide support to increase physical 
activity (e.g. by providing pedometers) and offer strategies for maintaining lifestyle 
changes17.  
The national program is commissioned and funded by NHS England and is delivered 
nationally by framework providers who are selected through a national commercial 
procurement process conducted every four years 16 18. The program can be delivered by 
both primary healthcare providers (e.g. community pharmacy and genera practice) and non-
healthcare providers (e.g. voluntary or private sector organisations).  
The program was first launched in 2016 despite systematic review evidence suggesting that 
its impact could be undermined by several factors including poor uptake amongst people 
with pre-diabetes 19. The review highlighted high withdrawal and attrition rates in clinical 
trials associated with evidence for DPPs, with only 27% of the identified population with pre-
diabetes completing the intervention. Similar findings were also identified in a study 
evaluating an existing community-based DPP in England 20 21. The study demonstrated low 
uptake (23% of the targeted population) following initial invitation letters mailed from 17 




intervention and control arm. Early progress reports on the uptake of the NHS DPP indicate 
that of those referred to the program, 49% attend initial assessment and between 36% and 
55% decline to participate 17 22. Additionally, of those who accept to participate, a further 
cohort of between 26% and 50%, do not progress onto the group based sessions17. 
Although, there is currently no published research investigating reasons for low uptake of the 
NHS DPP, evidence from qualitative research investigating participation in DPPs has 
highlighted accessibility, work and social commitments and practical challenges with 
organising group-based session times to be amongst the common barriers to participating23.  
Systematic review evidence suggests primary healthcare and community settings have the 
greatest reach to people with pre-diabetes 24 25.  In England, community pharmacy is the 
most visited primary care setting and is accessible to approximately 90% of the population 
within a 20-minute walk 26-28. The settings’ often convenient locations and extended opening 
hours (including weekends) 29, directly addresses some of the identified barriers to DPP 
uptake30. In other countries such as the USA, where the implementation of a national DPP 
has demonstrated success in achieving both weight loss and increasing physical activity,  
recommendations for further expansion 31 have resulted in the development of clear 
guidance for the delivery of DPPs in settings such as community pharmacies 32.  
 
In the UK , however, despite guidelines recommending delivery of DPP in primary healthcare 
settings, there are currently no community pharmacy-based Diabetes Prevention services 
(DPS) being provided4. Although some community pharmacies deliver opportunistic 
screening and mainly refer to general practice services 33 34, there are currently no routine 
lifestyle interventions being delivered in this setting for people with pre-diabetes and neither 
are there clear guidelines of how community pharmacy teams could deliver lifestyle 
interventions for this population. 
 
Additionally, barriers and facilitators to engagement in the current program are largely 
unknown. Although previous research has identified likely barriers and facilitators to 
participation, DPP interventions delivered in the studies were dissimilar to the current NHS 
DPP and included factors likely to enhance participation. For example, Laws et.al. describe 
an intervention with a significant involvement of healthcare personnel such as general 
practitioners, nurses and dieticians, a factor which was identified as influencing participation 
in DPPs 30. Similarly Smith et.al. also describe an intervention which included factors that 
potentially encouraged participation including involvement of social (partners) and external 
support networks (telephone calls from health coaches) 21 35 36. Therefore, with the current 




and personalised support, it is important to establish contextual barriers and facilitators to 
participation in the program in order to establish the context in which community pharmacy 
may play a role. 
 
The COM-B approach offers a theoretical model for identifying key factors influencing the 
desired behaviour 37 38. The model recognises that behaviour (B) is brought about by 
interacting components including Capability (C), Opportunity (O) and Motivation (M). The 
COM-B model forms the hub of the Behaviour Change Wheel (BCW), and is linked to 
intervention functions and policy categories that could be used to select and design 
appropriate interventions38 39. In this study, the COM-B was applied to understand two target 
behaviours: (1) people with pre-diabetes engaging in the NHS DPP and (2) people with pre-
diabetes engaging with community pharmacy-based diabetes prevention services (DPS). 
Analysing these behaviours using the COM-B would help identify behavioural determinants 
and assist in developing future interventions that could enhance engagement of people with 
pre-diabetes in community pharmacy-based DPS through the application of the BCW. The 
development of community pharmacy-based DPS, however, are beyond the scope of this 
research. The aim of this research is to explore factors influencing engagement with the 
current NHS DPP and elicit views from people with pre-diabetes on the role of the community 
pharmacy in diabetes prevention using the COM-B to frame the data collection, analysis and 
future direction of interventions aimed at patients and healthcare professionals. The term 
‘engagers’ as used in this study referred to participation sessions of the NHS DPP whether 
partial, current or complete whereas ‘non-engagers’ referred to participation in none of the 
sessions. This study therefore adopted five categories referred to as ‘engagement status’ to 
describe participant engagement with the NHS DPP and these included ‘dropped out (partial 
engager)’, ‘attending (current engager) ’, ‘completed (complete engager)’, ‘declined (non-
engager)’ and ‘waiting for assessment (non-engager)’.  These groups were adopted from the 












Study design  
This research adopted a pragmatic epistemology and used mixed methods consisting of a 
questionnaire, a focus group and interviews to address the study objectives 40. Ethical 
approval was obtained from the Health Research Authority (IRAS project ID: 227930) before 
commencing the research. The study took place in Norfolk between November 2017 and 
May 2018. 
 
Rationale for study design  
This study adopted the explanatory sequential mixed method design whereby qualitative and 
qualitative data are collected sequentially in two phases41. The questionnaire data were 
collected and analysed in the first phase and in the second phase, qualitative (interviews and 
focus group) data were collected and analysed to explain or to get a deeper understanding 
of the findings from the questionnaire. 
The questionnaire method was adopted following a literature search of factors influencing 
participation in DPPs which provided sufficient insight to enable the exploration of 
engagement in the current NHS DPP 23 35 42. The questionnaire also provided the most 
efficient way, in terms of time and cost, to obtain data from a large sample of participants 43. 
A focus group and semi-structured interviews were conducted in order to facilitate a deeper 
understanding of questionnaire responses with regards to influences on engagement with 
the NHS DPPs and the role of the community pharmacy in preventing type 2 diabetes 44.  
Focus groups were the preferred data collection methods as they are especially useful for 
confirming insights from a wide variety of participants 44. In this study which enrolled 
participants with diverse experiences of engagement with the NHS DPP and community 
pharmacy services, it was important for data generation to include an exchange of 
viewpoints and experiences in order to give participants the opportunity to reflect and 
consider their own standpoint in light of what they hear from others. Thus in this study, the 
use of focus group discussions, which is thought to facilitate the refinement of individual 
responses, was viewed to be appropriate 44. 
In order to provide a more accessible option to the studied population and encourage 
participation, an option of either face to face or telephone interviews was given as an 







Routine NHS DPP inclusion criteria  
General practices: All general practices operating within the 27 areas selected for the initial 
implementation of the NHS DPP in England (Including Norfolk) were eligible to provide pre-
diabetes screening and referral services to the NHS DPP. Participating general practices 
were primarily required to identify eligible individuals for referral to the NHS DPP by 
performing retrospective screening of their databases. 
People with pre-diabetes: People with pre-diabetes were primarily identified for referral to 
the NHS DPP during routine primary care appointments or through retrospective screening 
of general practice databases. Eligible patients for referral were individuals who were 18 
years or over and had an HbA1c blood tests within the pre-diabetes range (42-47mmol/mol 
(6.0-6.4%)) in the last 12 months 45. Following identification, individuals were sent letters 
communicating their risk and inviting them to participate in the NHS DPP in order to lower 
the risk of developing type 2 diabetes 46. At this point patients could voluntarily enrol onto the 
program by contacting the providers via a telephone number highlighted in the referral letter. 
General practices kept track of individuals identified through screening based on feedback 
they received from NHS DPP providers. 
 
Study recruitment 
General practices: General practices were the participant identification site for this 
research. All general practices in Norfolk who were participating in pre-diabetes screening 
and referral to the NHS DPP were eligible for the study. Participating general practices were 
identified via the North Norfolk Clinical Commissioning Group (CCG), an NHS organisation 
responsible for the planning and commissioning of healthcare services for the local area 
At the time the study commenced the NHS DPP was undergoing implementation across 
Norfolk. Therefore, to ensure the recruiting of participants who had adequate experience 
with the NHS DPP, only practices that had been participating in the NHS DPP for at least six 
months were invited to participate in the study by the research team. Participating general 








People with pre-diabetes  
Identification of eligible participants was performed by general practice staff by retrospective 
screening of databases. All patients who met the following inclusion/exclusion criteria were 
invited to participate:  
Inclusion criteria 
• Registered with a GP practice in Norfolk 
• Referred to the NHS DPP in the previous 12 months  
 
Exclusion criteria 
• Non-English speaking 
• History of type 2 diabetes 
• Unable to give consent  
 
Following identification of potential participants by general practices, questionnaires provided 
by the research team were mailed to eligible participants. As part of the questionnaire, 
participants were given an option to express an interest in interview or focus group 
participation. Identification of participants was anonymous with the researchers not seeing 
any patient identifiable data until completed questionnaires were returned to the research 
team.  
 
Sampling and sample size 
 
Questionnaire 
At the time of conducting the study, the NHS DPP was undergoing implementation in 
Norfolk, which was one of the first wave of 27 areas across the UK. North Norfolk and 
Norwich, consisting of 60 general practices in total, were the initial areas to start the 
screening and referral processes.  Based on participation data provided by North Norfolk 
CCG we planned to approach all 9 practices that had completed the identification and 
referral processes within these areas. These practices had a recorded total of 1,570 patients 
who had received a letter inviting them to participate in the NHS DPP and has initiated first 
contact with the providers. Based on the assumption that, all 9 practices would participate in 
the study, we planned to mail questionnaires to all 1,570 patients. Based on previous work, 
which used a similar method of recruiting a 10-20% response rate was expected, giving 150 
to 300 questionnaire responses. Questionnaires were sent to all eligible participants 




Interviews and focus group 
Participants expressing willingness to be contacted for the qualitative element were identified 
from returned questionnaires. To gain the perspectives of both engagers and non-engagers 
in the NHS DPP, a purposive sampling method, based on questionnaire responses was 
used to select participants 44. Selection of participants was primarily based on NHS DPP 
engagement status. Diversity was further sought by selecting participants according to 
employment status and community pharmacy use. The aim was to achieve maximum 
variation with regards to engagement with the NHS DPP and to obtain a diverse experience 
with community pharmacy service use. With respect to age, gender and employment, as 
most participants were older, female and retired, balance was sought by specifically also 
targeting younger, male or employed participants. 
Selected participants were sent an invitation letter and an information sheet and were given 
at least two weeks to read the information sheet before making a final decision to participate 
in the research. The selection of participants was an iterative, ongoing process whereby 
selection criteria for subsequent interviews were constantly being modified to ensure 
intended diversity of participants was achieved. The selection of participants and data 
collection was therefore performed in parallel between December 2017 and April 2018. The 
number of interviews and focus groups conducted was based on participants’ availability and 
data saturation44. In this study data saturation was determined by the degree to which new 
data was expressed in previous data and thus had an emphasis on data collection rather 
than data analysis. Data saturation was therefore determined when there was no additional 
data expressed in new data47.   






The questionnaire consisted of 4 sections which collected the following information: 1) 
demographics including NHS DPP participation, 2) feedback on the NHS DPP including 
accessibility, 3) community pharmacy use including general views on community pharmacy 
based DPS, and 4) expression to participate in further research. The full questionnaire has 
been provided in Appendix 1.The first 3 sections consisted primarily of Likert scale questions 
and also included open ended questions in order to cover topics that had not been 




asked to provide comments on various aspects of the programme and those who had not 
engaged were asked to comment on influences behind their decision.  
 
Questions exploring general views on potential engagement with community pharmacy 
based DPP were formulated by the research team 37 48, to explore participants’ views on the 
use of the setting for delivering DPS as well as willingness for participation.  
Questions exploring NHS DPP accessibility were based on previous qualitative research 
which had identified common barriers and facilitators to participation 23 35 42. The 
questionnaire, although primarily designed to validate accessibility barriers and facilitators 
identified from previous qualitative research within the context of the NHS DPP, also sought 
to explore other factors influencing engagement with the NHS DPP. 
 
Interviews and focus groups 
Interviews were conducted by the chief investigator (TK) and lasted up to one hour. The 
focus group was conducted by two members of the research team (TK and MT) at the 
University of East Anglia and lasted approximately 90 minutes. The focus group and 
interviews were digitally audio recorded and a semi-structured topic guide based on the 
COM-B model 37 was used to facilitate the discussions (Appendix 2). Topics explored 
included experiences with pre-diabetes diagnosis, influences behind engagement or non-
engagement, experiences with the NHS DPP or alternatives, experiences with community 
pharmacy services and views on community pharmacy delivering DPS. Researchers 





SPSS statistics (version 23; IBM Corp) was used for questionnaire data analysis. Medians 
(Interquartile ranges (IQs)) were used to describe the data. Data was explored to identify the 
distribution of respondents’ feedback on the NHS DPP, community pharmacy use and views 
on community pharmacy based DPS.  To conduct inferential statistics on influences of NHS 
DPP accessibility on participation (location and session times), program outcomes (weight 
and physical activity) and feedback on the program (satisfaction and perceived need for the 
program) participants were separated into groups based on their engagement (i.e. engagers 
and non-engagers) (Kruskal-Wallis test and Mann Whitney U). Additionally, descriptive 
analysis (n (%) and Medians (IQs)) was performed to analyse data on community pharmacy 
use. Participants were again separated into groups based on their use of community 




involvement of community pharmacy in delivering DPS (Mann Whitney U). Data from 
participants who had their engagement status and community pharmacy use missing were 
excluded from relevant sections of the analysis. 
 
Qualitative element: Interviews and focus groups  
Interview and focus group recordings were transcribed verbatim by a member of the 
research team or a paid transcription contractor, loaded in NVivo 11, and then checked for 
accuracy by listening back to the original recording (TK). All written comments made on the 
open-ended sections of the questionnaires were transferred onto a Word document and 
combined with interview and focus group data in NVivo for analysis. To provide an iterative 
process Braun and Clarke’s six phases of thematic analysis was utilised 49.  
 
Transcribed data were read and re-read to gain an overview of the content and identify 
topics of interest that were linked to the research questions (1. Familiarisation). The 
transcribed data was then re-read and inductively coded by the main researcher (TK) (2. 
Inductive coding). The coding process was then discussed with another member of the 
research team (MT) to assist the development of themes. Relationships between the codes 
were sought in order to develop subthemes and subsequent themes by two members of the 
research team (TK and MT) (3. Development of themes). Any disagreements were resolved 
by consensus following discussion, referring back to the coded and original transcripts. 
Transcripts were again revisited by a member of the research team (TK) to ensure 
correspondence between the developed themes and the data and to develop a richer 
description of the themes (4. Reviewing themes). Each theme was given a name which 
captured the essence of the contents and transcripts were again revisited to identify 
representative extracts to use in the written analysis (5. Defining themes). Extracts were 
selected to ensure a balanced representation of participant characteristics in terms of 
engagement with the NHS DPP and study involvement (questionnaire, focus groups and 
interviews). Theme descriptions and extracts were discussed with another member of the 
research team (MT). A narrative of the themes was written using extracts identified as 
illustrative evidence (6. Reporting).  
To obtain a deeper understanding, codes of the themes associated with two target 
behaviours i.e. (1) people with pre-diabetes engaging in DPP and (2) people with pre-
diabetes engaging with community pharmacy based DPS, were categorised as barriers and 
facilitators to facilitate further mapping onto the components of the COM-B model. Mapping 




COM-B model where Capability can be either ‘physical’ (e.g. physical skills) or 
‘psychological’ (e.g. knowledge) ability to perform the behaviour; Opportunity can be 
‘physical’ (e.g. Resources) or ‘social’ (e.g. interpersonal influences); Motivation may be 
‘reflective’ (e.g. beliefs about what it good or bad) or ‘automatic’ (e.g. processes involving 
wants and needs).  
 
Mapping processes were conducted with reference to the target behaviours and aided by 
discussion amongst the research team 44. The process involved mapping coded interviewee 
narratives to relevant COM-B categories. However, where there was overlap between COM-
B categories, discussions were held amongst the research team and interviewee narratives 
mapped to the COM-B category relevant to the “primary determinant”. The ‘primary 
determinant’ was considered as the starting point / root cause of a barrier or facilitator.  
Mapping was conducted by the main researcher (TK) and then discussed with another 
member of the research team (MT). The final mapping was then re-analysed independently 
by another member of the research team with expertise in psychology and using the COM-B 
(HF). Any disagreements were resolved by consensus following discussion with two other 





Questionnaire: NHS DPP 
Nine hundred and sixty-two questionnaires were posted via five general practices which  
agreed to participate resulting in 181 (18.8%) responses. Participants’ demographics and 
NHS DPP engagement status are summarised in Table 1. The majority of the respondents 
were white 176 (97.8%) and almost half reported to have either completed the program or 
were still attending sessions. A quarter of respondents reported to be waiting for an initial 
assessment following contact with the service providers.  
 
Feedback on the NHS DPP is summarised in Table 2. There were significant differences 
between the groups in terms of convenience of program location and session times with a 
general trend being towards agreeing or strongly agreeing for those who were attending, had 
completed or had dropped out of the program compared to those who had declined or were 
waiting for an initial assessment (Kruskal-Wallis test: p < 0.001 ((X2 = 38.69, df = 4) and p < 





There was also a variation between ‘non-engagers’ (waiting for an initial assessment and 
declined) with regards to feeling the need to attend the program. Those who had declined 
agreed to feeling that they did not need the program (Mann Whitney U, p=0.014) whilst 
those who were waiting had no strong views about whether they needed the help of the 
program. Overall feedback on the NHS DPP from ‘engagers’ (attending, completed and 
dropped out) was positive. There was little variation in feedback about program outcomes, 
with most respondents reporting the program to have successfully helped them in achieving 
weight loss and increasing physical activity. However, overall satisfaction with the program 
and views concerning the helpfulness of group sessions varied amongst the three groups 





Table 1: Questionnaire participant characteristics  
Characteristics N Measure Classification 
 
Responses   
Replied 962 % (n)  
 
18.8 (181) 
Female  180 % (n)  57.2 (103) 
 
Age (Years) 180 Mean (SD) 
 
 




181 % (n) Employed 22.7 (41) 
 
 Student 5 (9) 
 







NHS DPP engagement 
status 
167 % (95% CI) Waiting  25.7 (19.1, 32.2) 
 Attending  24.6 (18.1, 31.1) 
 Dropped-out 
 
9.6 (5.1, 14.1) 
 Completed 25.1 (18.5, 31.7) 





Table 2: Feedback on NHS DPP 
Likert scale: strongly disagree (1), disagree (2), neither agree nor disagree (3), agree (4), strongly agree (5) 
 
* Kruskal-Wallis Test 
 
** Mann Whitney U












The location of the programme was 
convenient for me  
 
3 (3,4.75) 4 (4,5) 5 (4,5) 4 (4,5) 3 (2,3) <0.001 * 
 
The times that the sessions were 
offered were convenient for me  
3 (2, 5) 4 (4,5) 5 (4,5) 3.5 (2,4) 
 
 
3 (2,3.5) <0.001 * 
 
I found attending the sessions as a 
group helpful 
 
- 4 (4,5) 5 (4,5) 4 (3,4) 
 
 
- 0.019 * 
The programme has helped me or is 




4 (4,5) 4 (4,5) 4 (2,4) - 0.075 * 
 
The programme has helped me or is 




4 (3,5) 4 (3,4.75) 4 (2,4) - 0.045 * 
 
Please indicate your level of 




4 (4,5) 5 (4,5) 3 (2,4) - 0.001 * 
I feel like I need the programme  3 (3,4.25) 
 
 




Questionnaire: community pharmacy  
Most participants reported taking prescribed medication (88.6% (156)). In total, 59.5% 
reported collecting their medication from community pharmacy rather than dispensing 
general practices (practices that dispense medicines they prescribe to patients living 
remotely from a community pharmacy). Ninety three percent of participants on prescribed 
medication collected their medication in person. A larger proportion of respondents (82.8%) 
who collected medication from the community pharmacy reported visiting the pharmacy 
more frequently i.e. either once a month or most days than those who collected medication 
from dispensing doctors (54.1%). Most of the respondents who collected their medication 
from a local community pharmacy reported a shorter travel distance (1-2 miles, 90.4%) 
compared to those collecting their medication from dispensing general practices (+3 miles, 
44.3%).   
 
Table 3 summarises the reported use of community pharmacy services by respondents.  
Most respondents reported using community pharmacy for either over-the-counter services, 
information/advice or screening services. Just over a quarter of respondents reported to 







Table 3: Community pharmacy services use 
Which community pharmacy 
service have you used 
before? 
 




Over the counter advice 
 
Clinical advice on non-prescription medicines for a range of minor illnesses, 
such as coughs, colds, fungal infections, and aches and pains. This advice also 
includes diet and lifestyle recommendations and signposting to more appropriate 
services for more serious conditions 
 
29.7 (47) 
Blood Pressure check 
 
A blood pressure screening service 
 
25.3 (40)  
NHS Health check  
 
A screening service designed to predict the 10 year risk of developing heart 
disease and offer lifestyle advice and intervention where necessary. The check 
is for adults in England aged 40-74 and consists of a combination of weight 
measurements, blood pressure, blood glucose and cholesterol screening, diet 
and physical activity information 
 
19.0 (30)  
Cholesterol check 
 





Free health-related leaflets on various conditions including diabetes and 
hypertension 
   
16.5 (26) 







A one to one service delivered by trained pharmacy advisers that provides a 
range of proven smoking cessation methods. The program provides information 
and advice on stopping smoking, as well as professional support, during the first 
few months following cessation  
 
4.4 (7) 
Weight loss program  
 
A service delivered by trained pharmacists to support patients to lose weight 





Other services including seasonal influenza vaccination services and medicine 
related services (e.g. medicines use reviews)  
 
4.4 (7) 
None/never heard of these   
 











Table 4 illustrates the responses about the role of community pharmacy in diabetes 
prevention. People who collected medication from community pharmacy were more inclined 
to think that community pharmacy was capable of delivering DPS (p=0.023). Most 
respondents agreed that they would consider using community pharmacy for diabetes 
prevention services and would be motivated to attend community pharmacy based DPS. 
There was no significant difference in participants’ motivation (p=0.076) and consideration 
(p=0.124) to use community pharmacy for DPS between people who collected their 
































Table 4: Views on potential engagement with and delivery of community pharmacy diabetes prevention services  
 
Questionnaire statement  All participants 
 
















                                                          Median (IQ) 
I think community pharmacy is capable of 
providing a diabetes prevention service  
 
 
4 (3,4) 4 (3,4) 3 (3,4) 0.023 
I would consider community pharmacy for 
a diabetes prevention service  
 
 
4 (3,4) 4 (3,4) 4 (3,4) 0.124 
I would be motivated to attend a pre-
diabetes screening or prevention service 
provided by the community pharmacy 
team 




Interviews and focus groups 
One hundred and four respondents (57.5%) expressed an interest in the qualitative element 
of the study. With most participants opting for interviews, one focus group consisting of 6 
participants and 10 telephone interviews were conducted. Table 5 presents the 
demographics of the 16 participants purposively sampled to participate in the qualitative 
element. A participant identification key for the illustrative quotes used in this report is also 
provided in Table 5. There were slightly more females than males and more were retired 
than employed. There was an even distribution across those who had engaged with the NHS 
DPP (completed or attending (n= 6)) and those who had not (declined or dropped out (n=7)). 
The sample also included participants who were waiting for initial assessment (n=3). One 
hundred and forty-four participants responded to the open-ended sections of the 
questionnaire and these responses were included in the analysis. The thematic analysis 
produced four main themes 1) Perceptions of pre-diabetes 2) Factors influencing 
engagement in the NHS DPP 3) Feedback on the NHS DPP and 4) The role of community 
pharmacy in pre-diabetes. Two themes (‘Factors influencing engagement in the NHS DPP’ 
and ‘The role of community pharmacy in pre-diabetes’) were identified as closely linked to 
the target behaviours (‘people with pre-diabetes engaging in DPP’ and ‘people with pre-
diabetes engaging with community pharmacy based DPS’) respectively. Tables 6 and 7 
present the mapping of the codes associated with these two themes to the components of 
the COM-B model.  
 
1. Perceptions of pre-diabetes 
Participants expressed a lack of awareness of pre-diabetes prior to diagnosis. Reactions 
following diagnoses were mainly that of shock particularly due to positive self-perception 
about diet, lifestyle and lack of family history. Those who were not shocked were clearly able 
to relate the diagnosis to risk factors such as age, weight, family history, co-morbidities and 
poor dietary choices. Whilst a few participants were not concerned with the diagnosis and 
had made the conclusion that the risk of developing diabetes was not serious, others 
highlighted the need for earlier interventions, prior to a formal diagnosis of pre-diabetes, to 
address poor lifestyle behaviours before they became an issue.  
 
‘I know I’m a wee bit overweight but not extortionately and we have a very healthy diet in so much as 
we eat plenty of fruit and vegetables… nobody else in my family is diabetic so it did take me by 





‘I think you drift into bad habits and if someone says to you your blood sugars are increasing every 
time you might find it easier to amend your habits earlier on in the process rather than go and say 42 




































Table 5: Characteristics of interview and focus group participants  
 
Characteristic  Total (N=16) 
N (%) 




• Female  9 (56.3) 
 
Employment status  
 
• Employed  4 (25) 
• Retired 12 (75) 
 
Engagement status   
 
• Attending 3 (18.8) 
• Completed  3 (18.8) 
• Waiting  3 (18.8) 
• Dropped out 2 (12.5) 
• Declined   5 (31.3) 
 
Community pharmacy use   
• About once a month  4 (25) 
• Once every two to three months  1 (6.3) 
• Two or three times a year 8 (50) 
• Never 3 (18.8) 
 
Key for illustrative quotes:  
FG = focus group participant, I= interview participant, Q= participants’ 
response to open-ended questionnaire sections. All participant 

















2. Factors influencing engagement with the NHS DPP 
 
There were several factors that influenced participation in the NHS DPP following diagnosis 
of pre-diabetes. Table 6 summarises barriers and facilitators to engagement mapped to the 
COM-B, along with illustrative quotes. The target behaviour linked to this theme was ‘people 
with pre-diabetes engaging in DPPs’.  
 
Capability  
Physical ability to participate in sessions of the NHS DPP, particularly group exercises, was 
identified as a key enabler for engaging with and completing all program sessions. To this 
end some participants described being hindered by co-morbidities such as arthritis and only 
engaging in the educational elements of the program.  
 
Opportunity  
Program location, session times and transportation, contributed to both facilitators and 
barriers to engagement. Participants felt that session times, which run during working hours, 
were more accessible for those without work commitments. Social influences on uptake 
arose from a variety of networks including employers where some participants described 
employers allowing them to have time off work to attend sessions of the programme. Other 
participants, however, described making decisions to engage based on advice sought from 
healthcare professionals, particularly GPs and nurses. Some of these participants described 
practitioners advising them against participating based on their beliefs of the benefits of the 
program and the availability of spaces on the program.  
 
Motivation  
A variety of reflections influenced lifestyle changes and engagement with the NHS DPP. 
Participants’ perceived own ability of making dietary changes and increasing physical 
activity, without intervention from the NHS, influenced some to disengage from the national 
program. These participants described making changes which had resulted in positive 
outcomes such as weight loss, lower HbA1c and blood pressure. Group-based sessions also 
appeared to be a deterrent to some who acknowledged this to be attributable to personal 
preference.  
Participants also described making decisions to engage with the program based on 
perceived potential health benefits as well as perceived reliability of alternative sources of 
help such as online information. Participants’ beliefs about the consequences of type 2 
diabetes, which were mainly based on family history or other observations, also influenced 




inclined to engage with the national program others felt that their experience with the 
condition had given them enough information and knowledge to support them in making 
lifestyle changes and therefore chose not to engage. Emotional responses to diagnosis, 
particularly fear of diabetes and complications, served as motivators to making lifestyle 
changes or engaging with the program. Participants also described being motivated by self-
conscious intentions and goals such as losing weight or improving prognosis of co-
morbidities such as arthritis. Finally, one participant in particular felt strongly that their reason 
for wanting to engage with the help offered by the NHS DPP was influenced by their view of 
the role of the NHS and that they should be doing everything they can to prevent additional 



















Table 6: A COM-B analysis of factors influencing engagement with the NHS DPP  
COM-B model 
component 




Facilitators Illustrative quotes  
Capability 
 
Physical i.e. physical skill, 
strength or stamina to perform 
the behaviour  
 
• Co-morbidities  “My level of exercise has been hampered by other health 
problems” [Q-98, completed] 
 
Psychological i.e. knowledge or 
psychological skills, strength or 
stamina to engage in the 
necessary mental processes 






Physical i.e.  
opportunity afforded by the 
environment involving time, 
resources, locations, cues, 
physical affordance 
 
• Location  
• Transportation  
• Location  
 
“I don’t drive, so one of the questions I asked him [GP] where 
do these sessions take place, because if I need to go to 
[location] or somewhere to do it, it’s not easy you know. It 
adds another several hours to the day for me” [I-19 declined] 
 
• Session times  
• Social/work commitments  
 “It was a bad time of the day you know, effectively I lost a 
day’s work by the time I got up there and got back”                 
[I-81, dropped-out] 
 
Social i.e. opportunity afforded 
by interpersonal influences, social 
cues and cultural norms that 
influence the way that we think 
about things e.g. the words and 
concepts that make up our 
language 
 • Employer support  “It is quite a commitment though. I work full time and I’ve 
been very lucky in that my employers let me go every week” 
[FG-91, completed]  
 
Healthcare professionals’ influence •  “ I said ‘do I need to do this prevention programme?, because 
I am quite happy to do it if you think it is advisable’, and he 
[GP] said, ‘well I’m not sure it’s going to do you a lot of good, 
you’re already eating healthily and you’re losing weight’” [I-19 
declined] 
 
Motivation Reflective motivation i.e. 
reflective processes involving 
plans (self-conscious intentions) 
and evaluations (beliefs about 
what is good and bad) 
  
• Self-help (existing knowledge of dietary 
management) 
•  
•  “I think from my own diet management really I seem to have 
got myself back within the bounds or within the figures I 





 • Group-based sessions •  “I am not one for being in a mixed crowd, I’d rather be on my 
own” [I-29, declined] 
• Perceiving no additional benefit from 
the program  
• Perceiving positive health 
benefits from the program 
“I have a general idea you know. I listen to the radio and I 
watch television and you hear from programs there about how 
to cope with diabetes and how to make your lifestyle better, 
so I thought what am I going to gain by doing some yet 
another class as it were” [I-40, declined] 
 
• Family history • Family history “My brother has it [type 2 diabetes]. It’s a nuisance and it 
affects him in a way which I thought well I don’t want to be in 
that situation. In fact, I thought I am not going to be in that 
situation full stop.” [I-18 completed] 
 
 • Perceiving online information 
sources to be less reliable  
“In a way I was happy to wait for more expert advice, because 
whilst I obviously used internet and google to check things 
out, you get a lot of information, some of which is conflicting. 
So it’s not always the best source” [I-18 completed] 
 
 • Weight loss  “I’ve got to be fair and say I went more with the idea of trying 
to lose some weight than actually preventing diabetes. I’ve 
got to be honest about that” [I-42, completed] 
 
 • Saving NHS money “It’s a dreadful thing to think that I might be costing the NHS 
money because I am ill-disciplined, and that is really why I 
want to take it more seriously” [FG-32, waiting] 
 
Automatic motivation i.e. 
Automatic processes involving 
emotional reactions, desires 
(wants and needs), impulses, 
inhibitions, drive states and reflex 
responses. 
 • Fear of diabetes and 
complications  
“To be honest, I would hate to be diabetic. If I had to give 
myself injections I just don’t know how I could handle that. I 
know people who have had it affects other parts of your 




3. Feedback on the NHS DPP 
 
Feedback from participants who engaged with the national program, including those who had dropped out, 
largely reflected the ‘one size does not fit all’ notion with some giving positive feedback and others giving 
negative feedback on the same aspects. Participants who had attended some sessions or had completed 
the program described the location as accessible and session times as convenient whilst those who hadn’t 
engaged had opposing views including a lack of flexibility in program delivery. Participants who had 
attended some sessions of the program gave largely positive feedback and expressed positive outcomes 
achieved including raised awareness in making healthy dietary choices, weight loss, increased physical 
activity and reduced HbA1c. Some participants also reported positive outcomes with comorbidities such as 
blood pressure and arthritis. In terms of delivery, participants felt that the program was well presented by 
knowledgeable non-healthcare personnel and felt that delivery was consistent throughout its duration.  
 
“Well the location was very good for a start, it was very near the doctors and I go to the surgery so it was convenient 
for me” [I-7, attending] 
 
“I thought that the people that presented it, without being doctors, nurses, pharmacists whatever, did a very good job 
and I’m tempted to think they might also use a language that’s closer to that used by the participants than a medical 
professional” [I-18, attending] 
 
Participants also expressed the usefulness of resources offered by the program including written materials 
and props which helped them to gain a better understanding of pre-diabetes and dietary choices. However, 
some expressed a preference for simple written materials instead of the book provided by the program. 
Negative experiences appeared to centre on the notion that the duration of the sessions was too long, with 
some describing the 2-hour sessions as ‘heavy going’. Some participants also commented on aspects of 
the program such as exercise sessions that seemed irrelevant to them due to their age and co-morbidities. 
Group activities also received both positive and negative feedback with participants liking activities such as 
weighing and others not taking to some of the activities. Most participants who completed the program 
seemed to have a richer appreciation of the support and encouragement that the group-based sessions 
provided.  
 
“Only attended one session. Found it was very long, unnecessary and rather patronising” [Q161, dropped-out].  
“In the group I attended most of the people were 60 plus so the activities/exercise provided I think were for that age 
group and not mine” [Q-1, completed]. 
 
“A big benefit of the course was the group meetings. It wouldn't have meant anything to me if it hadn’t have been for 
that. I actually look forward to going every week and listening to what other people have done that week; what they 










4. The role of community pharmacy in pre-diabetes  
Quantitative analysis has indicated that people with pre-diabetes consider community pharmacy as capable 
of delivering DPS, with most agreeing that they would consider using this setting for such services.  Table 7 
presents identified barriers and facilitators for people with pre-diabetes engaging with community 
pharmacy-based DPS mapped onto the COM-B. The related target behaviour in this theme was ‘people 
with pre-diabetes engaging with community pharmacy based DPS’. 
 
Capability 
Generally, participants who were unable to engage with the current national program due to various 
accessibility factors (e.g. time commitments) expressed a lack of knowledge of where to access alternative 
help. Therefore, with most participants also expressing a lack of knowledge about current community 
pharmacy-based public health services, it was felt that people with pre-diabetes would need to be informed 
about DPS provided in this setting to enable them to engage.    
 
Opportunity 
The community pharmacy setting was identified by the participants as accessible and convenient, 
particularly in terms of location and ease of making appointments. Participants felt that there is an 
opportunity for community pharmacy to deliver pre-diabetes screening and monitoring services with some 
expressing their willingness to attend and even pay for the services. Participants felt that the DPS delivered 
in this setting would be most appropriate for regular community pharmacy users due to established 
relationships. 
 
A number of barriers that would have to be overcome to deliver the services such as lack of access to 
medical records, time, funding and staff resources were also identified. Whilst some participants felt that, 
due to space challenges, community pharmacy would be unable to deliver group-based sessions, others 
discussed concerns about privacy and confidentiality, which were mainly based on the set-up of community 
pharmacies and the tendency for advice to be given over-the-counter.   
 
Most participants felt that the integration of community pharmacy DPS with general practice services could 
increase acceptability of service users. Participants also felt that delivering DPS in this setting could 
potentially decrease GP workload and thus decrease waiting times at general practices.  Other participants 
who were less keen on the idea of community pharmacy delivering DPS explained that the service would 
be better provided by the general practice alone due to their increased access to medical records and 
familiarity. However, some participants acknowledged their views were based on pre-conceived ideas of 
the role of community pharmacy and reservations about them providing services that traditionally would be 
otherwise provided by general practices. Experiences with current community pharmacy services were 
largely medicine related and involved information provision or counselling. Apart from influenza 




screening, offered in this setting. Generally, due to the lack of awareness of current community pharmacy 
services and its public health role, participants felt that community pharmacy based DPS would need to be 




Motivations to access community pharmacy based DPS were largely reflective, where participants 
described basing decisions on their experiences and beliefs. Most respondents felt that delivering pre-
diabetes screening and DPPs through community pharmacy was a good idea with some expressing that 
the setting could provide an alternative to those who don’t like the group-based setting of the current 
national program. Those who had either completed the national DPP and had managed to revert their 
HbA1c levels to normal ranges expressed that this setting could be useful for providing follow-on support 
and monitoring and would give them peace of mind due to ease of access.  
 
Participants acknowledged that community pharmacy has the potential to deliver DPS but considered 
appropriate training and qualifications of personnel delivering services as key determinants for enhancing 
their motivation to engage.  This indicated that participants were comfortable with the community pharmacy 
personnel delivering DPS as they felt it could be delivered by anyone providing they had the appropriate 
training. This aligned with other participant views about non-healthcare professionals delivering the NHS 
DPP successfully.  
 
Willingness to participate in community based DPS was largely influenced by participants’ experience with 
other services in this setting, with those who had negative experiences with prescription services strongly 
opposing the concept of community pharmacy delivering diabetes prevention interventions. Additionally, 
some participants who had attended the national DPP were sceptical about community pharmacy being 
able to deliver DPS. These participants expressed that having attended the current national program, which 
from their experience was a lengthy and comprehensive service, they were finding it difficult to envisage 



























Physical     
Psychological  • Knowledge of appropriate 
healthcare pathways  
 “There are just so many avenues you can get medical advice through 
nowadays, and it gets very confusing”  
[Q-25, waiting] 
 
Opportunity  Physical  
 
 • Convenient “It sounds like a convenient way for people to access screening and 
advice on how they can best avoid developing full blown diabetes” [Q-
94, attending] 
 
 • Accessible location “An excellent idea. Closer to home is a huge improvement. No long 
1hour+ on cold wet days - that’s 1hr minimum - on my trip into 
[location]” [Q-48, declined] 
 
• Inability to deliver group-based 
sessions 
• Space challenges 
 “I feel the group setting is a good way forward for a prevention service 
and I am not sure if this can be provided by community pharmacy with 
limited space” [Q-110, completed] 
 
 
• Confidentiality and privacy concerns  “Would there be a private room available or enough space if it’s a 
course and privacy and confidentiality. I hope it wouldn’t be held or 
reviewed at the shop counter” [Q-103, unknown participation status] 
 
• Busy 
• Uncertainty regarding appointments   
 “Not sure if this would work as they always seem to be quite busy, 
unless it was done in appointment system” [Q114-completed] 
 
 • Shorter waiting times 
 
“Probably far quicker than waiting for doctor’s appointment. Prevention 
screening services? Excellent idea if carried out by professionals 
targeting specific ailments include "Wellman Clinic" [Q127-waiting] 
 
 
• Lack of access to medical records  “I think the doctors have more accessibility to medical records for 
contacting people but the community pharmacy is always there for 





 • Potential to save GP time “That could actually save the doctors an awful lot of time and 
especially the climate at the moment is that hospitals doctors surgeries 
are at bursting point…it would be very useful for a chemist to take 
some of these more simple things which are very important to the body 
on board and free the public from standing in queues and free the 
surgeries from having too many people to attend to” [I-7, attending] 
 
• Understaffed • Extra resources e.g. 2 pharmacists  “I don’t feel that community pharmacies have the resources to provide 
an effective diabetes prevention services as this would require lengthy 
consultations to cover the many aspects involved” [FG-11, attending] 
 
• Funding cuts • Funding  “I think community pharmacy I think would be it’s not so much a 
commercial thing if you want would probably be a better option I’d love 
to see it but it’s going to take a lot of investment in time people and 
money” [I-18 completed] 
 
 • Potential to provide HbA1c 
monitoring 
“If technology is moving away from having to send blood samples 
away and having to wait days for them to come back to the surgery…  
if modern equipment is able to do that in a pharmacy setting maybe 
there’s an opportunity that might work” [FG-11, attending] 
 
 • Willing to pay for screening services “If there’d been some way I’d have even paid for it to monitor my 
health in some way, which is where I was thinking you know 
community pharmacy if you could pay them to test you when you’re 35 




• CP underutilised in England 
•  
•  
• Lack of awareness of community 
pharmacy services 
• Promotion of community pharmacy 
services 
“ If you go abroad I mean in other countries the pharmacist is usually 
the first port…even in European countries where you don’t pay for 
healthcare necessarily you go [to] a pharmacist to get advice” [FG-25, 
waiting] 
 
“I’m not aware of all the different things that chemists do, I didn’t think 
they probably would measure your cholesterol and things like that I 
suppose it’s possible” [I-7, attending] 
• Division between pharmacy and the 
rest of the medical profession 
• Diabetes prevention services must 
be linked to GP 
“You’ve got all sorts of people who have become involved with the 
surgery who weren’t before…same with the pharmacist, if it was within 
that environment and they were all linked together and they had that 
interaction I think people would probably have more confidence” [FG-
11, attending]  
 
Prefers GP or nurse due to 
established relationship and cultural 
norms 














 • Possible alternative to group-based 
sessions 
“Possibly useful alternative to group sessions” [Q-166, dropped-out] 
 • DPPs can be delivered by any 
trained personnel 
“I mean these courses were given by people who weren’t doctors or 
pharmacist and hadn’t had that amount of training, but they were 
trained to deliver this course and that was fine. I didn’t need to have 
somebody who’s got a degree” [FG-42, completed] 
 
Qualifications • Training 
• Pharmacists’ knowledge and 
qualifications 
“The staff are very capable for my use so far, and I see no reason why 
with training they [community pharmacy staff] would be unable to do so 
[deliver DPS]” [I-29 declined] 
 
 
 • Community pharmacy can provide 
support after NHS DPP 




Sceptical about community 
pharmacy being able to deliver 
DPPs 
•  “It is so detailed and comprehensive [NHS DPP] that I’m finding it 
difficult how a local pharmacy is going to be able to provide that sort of 
advice, service and encouragement” [FG-11, attending]  
 
• Negative experiences with 
community pharmacy services  
 
 
Little or no experience of using 
community pharmacy services 
• Positive experiences with 
community pharmacy services 
“Having to wait at least 30 minutes in my pharmacy to collect 
prescriptions, they seem very disorganised with no system. I feel they 
would not be capable of providing this service efficiently” [Q-104, 
declined] 
 
“I haven’t really had any experience with pharmacies…well I guess I’d 
have to trust them [to deliver DPS]. As I say I have no experience of 
ever going to them before, so I can’t judge them on no experience” [I-
115, dropped-out] 
 
Automatic  • Community pharmacy monitoring 
service would give patients peace of 
mind 
“I think to be able to go in for peace of mind cos I know sometimes I 
feel that if I’ve gone too long and not eaten my blood sugar goes 






This research highlights that a one-size fits all approach should not be applied when 
delivering the DPP and that alternative delivery approaches should be explored to maximize 
reach 23. Factors influencing engagement identified by this research not only highlight a 
potential role for community pharmacy in addressing accessibility barriers but could also 
inform pathways for signposting people with pre-diabetes into better suited DPP settings. 
This study also identifies important facilitators in the Capability (e.g. knowledge) and 
Opportunity (e.g. session times) domains of the COM-B theoretical behaviour change model 
that could be targeted when designing and implementing pre-diabetes interventions that 
could be delivered by community pharmacy teams.   
 
The experience of being diagnosed with pre-diabetes, largely described as a feeling of shock 
by the participants in this study, and the subsequent motivation to make lifestyle changes, 
highlights a timely opportunity for the provision of suitable interventions in people with pre-
diabetes. Previous research has highlighted the diagnosis of pre-diabetes as a ‘window of 
opportunity’ for healthcare professionals to support those diagnosed with pre-diabetes to 
implement lifestyle changes 50. This research demonstrates scope for community pharmacy 
teams to deliver DPS for people diagnosed with pre-diabetes following screening as an 
alternative option to the current national program. Community pharmacy, well known for its 
accessibility, including long opening hours and weekends, was seen by people with pre-
diabetes as a potentially accessible and convenient option, particularly for regular service 
users.  Previous research exploring views and perceptions of the public towards community 
pharmacy screening services and its public health role has shown similar findings, identifying 
accessibility and convenience as positive aspects of community pharmacy 51-53. However, in 
line with previous research, our findings have shown that although the community pharmacy 
setting could be a favourable choice for people who are employed and regular service users 
54 55, engagement could be hindered by lack of awareness of community pharmacy services 
and poor perceptions of the role and expertise of community pharmacy teams 51 54 56. 
Additionally, strong views of pharmacists as drug experts 57 58, preference for general 
practice settings by patients 59 and lack of GP endorsement have also been highlighted by 
research as common hindrances to community pharmacy services uptake 23 42 55. 
 
In 2016, a review of community pharmacy clinical services in England highlighted similar 
behavioural constraints for accessing community pharmacy services including lack of 
awareness and expectation of the clinical care that pharmacy can and could deliver by 




awareness of community pharmacy services as well as increasing public perception and 
experience is crucial for changing behaviours. The review recommended building local peer 
relationships with other healthcare providers and using patient groups to raise awareness to 
people with different cultural backgrounds and age groups 60. 
 
This study demonstrates that engagement with community pharmacy based DPS could be 
influenced by perceptions of community pharmacy teams’ capability (in terms of training and 
qualification) to deliver such services. Although this research indicates that regular 
community pharmacy users are more inclined to perceive community pharmacy to be 
capable of delivering DPS, the findings show that most people with pre-diabetes would be 
willing to engage with services in this setting if community pharmacy teams received 
appropriate training. A systematic review examining the beliefs and attitudes of consumers 
towards pharmaceutical public health, has shown similar findings suggesting that although 
most service users view pharmacists as appropriate providers of public health advice, they 
have mixed views on pharmacists' ability to do this 61. The review also found high 
satisfaction rates amongst those that had experienced community pharmacy based public 
health services and recommended the provision of training to increase pharmacists' 
confidence in providing these services. 
 
Other intervention characteristics such as program content and delivery, seemed to 
influence retention of people with pre-diabetes following initial engagement. Characteristics 
such as session times and duration, were among factors identified by our study to influence 
those who dropped out of the national DPP. This reflects findings of the ComPoD study 
which evaluated an existing community-based DPP in parts of England (Exeter and 
Birmingham) and reported a similar proportion of people who had declined or dropped out 20. 
The ComPoD study also identified inconvenient session times as a common barrier amongst 
non-engagers. Previous qualitative research which identified organising suitable session 
times for a group as a challenge for providers identified the need for session time flexibility in 
program delivery and ensuring sufficient physical access including transportation and 
parking 23.  
 
Finally, as this research suggests motivation to be an important factor influencing 
participation in DPPs, the provision of DPS in alternative settings to such as community 
pharmacy, which primarily serve to increase opportunity for engagement, could indirectly 
enhance motivation38 39.   This study also identified motivational factors such as patients’ 
perceptions of their ability in making health choices and perceived reliability of alternative 




Such factors would therefore need to be taken into account when considering the primary 
targets of the NHS DPP. It is also important that patients motivated to make lifestyle 




Strengths and limitations  
This is the first study investigating influences of participation in NHS DPP and exploring the 
role of community pharmacy in diabetes prevention. Demographic characteristics, which 
largely consisted of an elderly population, including a small proportion of employed people 
and fewer men than women, sufficiently represented that of Norfolk which largely consists of 
a white British population with a relatively older age profile compared to the rest of England 
64. Participation demographics reflected both national NHS DPP figures and previous 
research which demonstrate increased uptake with age and a significantly lower attendance 
in men 22 23 42 65 66. Additionally, participation rates reflected local figures which demonstrate a 
56% (95% CI 53 to 60) uptake rate (attendance of initial session ) since initiation of the 
programme in June 2016 22.  
 
The mixed method, exploratory design enabled triangulation of findings to gain views of a 
wider pre-diabetes population. Using a theoretically informed approach to investigate the 
role of community pharmacy in diabetes prevention in this research presents a potential to 
inform development and implementation of services for people with pre-diabetes in this 
setting. The findings could also inform possible screening methods for signposting patients 
into better suited DPP settings.  
The barriers and facilitators mapped to the COM-B components of this research will be taken 
forward to inform the development of a role of community pharmacy in diabetes prevention. 
Further work will look at linking the outcomes of this research through the Behaviour Change 
Wheel, a framework for developing behaviour change interventions 38 39, to develop 
appropriate interventions and strategies that could increase participation in both DPPs and 
also community pharmacy-based services. . This future work will also include components 
identified in a parallel study which explored the study objectives in healthcare professionals 
and commissioners 67.  
One of the limitations of the study was the lack of diversity thus providing a limited 
perspective from people of other ethnic backgrounds. Additionally, the exclusion of non-




both the NHS DPP and in this study, thus limiting the generalisation of findings to 
subpopulations68. Another limitation was the low response rate to the questionnaire study 
which limited the number of questionnaires included in the analysis. With the majority of 
respondents constituting those who had expressed some interest in participating in the NHS 
DPP, social desirability may also be a bias in the responses received 69.  The use of an 
unvalidated questionnaire incorporating agree/disagree Likert scale, a scale which research 
suggests achieve results with lower reliability and validity due to acquiescence and cognitive 
burden, also poses a limitation in this study 70. Furthermore, the exclusion of questions 
exploring perceived need of the program in engagers was a limitation that precluded further 
inferences to be made as to whether perceived need was a key barrier or not.    
 
Rigorous methods were adopted for the conduct and reporting of this research to ensure 
trustworthiness of the findings 71. Triangulation of methods, achieved by using multiple 
methods of data collection including interviews, focus group and questionnaire added to the 
credibility of the research findings 72. Additionally, investigator triangulation was applied by 
involving several researchers, with a range of expertise, in conducting data analysis. 
Transparency in describing research steps taken from study initiation to the reporting of the 
findings has been provided. A detailed description of the context and setting of the study, 
including the delivery and funding of the NHS DPP has also been provided to ensure 
transferability of the data 71 73. Additionally, the processes and methods used in this research 
including participant inclusion and exclusion criteria, sampling strategy, topic guides and 
questionnaire have been thoroughly described to ensure that this research can be 
transferred to other contexts and settings. The analytical process of the study, particularly 
the mapping of barriers and facilitators to the COM-B theoretical model, was examined by an 
external psychologist (HF) with experience of applying the COM-B in designing 
interventions. This ensured that the interpretation of the findings was supported by data 
received from participants of the study, hence enhancing dependability and confirmability of 
the research findings 71.  
The community pharmacy background of the main researcher (TK) could have influenced 
the analysis processes 74. Therefore, in order to minimise the researchers’ subjective 
influence on the interpretation of the findings, analyst triangulation was used to provide 
multiple perspectives in interpretation of results 75. This was achieved through regular 
discussion with members of the research team during analysis to discuss the findings until 
the interpretation which best represented the meaning of the data was found.  The 




MT, HF and CK), primary care research (MT) and psychology (HF). Additionally, the 
inclusion of participants with a diverse experience with community pharmacy services 
facilitated the presentation of balanced views about the potential role of community 




Community pharmacy is an acceptable setting for the delivery of DPS and could be a 
favourable alternative for people with work and social commitments, regular community 
pharmacy users and those seeking alternatives to the current national program. This 
research outlines factors that could influence the implementation of services in this setting 
with regards to engagement. Opportunity to engage with community pharmacy-based DPS 
services arises from its accessibility. Therefore, if community pharmacy were to provide DPS 
with flexible session times, which is possible given their extended opening hours, this could 
present a potential role for the setting in addressing some of the current barriers to 
engagement. Patient perceptions of community pharmacy’s capability of delivering 
acceptable DPS could be influenced by knowing that community pharmacy teams are 
appropriately trained to deliver the services.  In order to enhance motivation for people with 
pre-diabetes to engage with DPS, community pharmacy teams would need to build trusting 
relationships with this population and ensure endorsement by healthcare professionals such 
as GPs and nurses. The data in this paper provides evidence to inform intervention 
development as per the aims of the COM-B model of behaviour change. Further research, 
involving a thorough process evaluation alongside, would also be required to test the 
feasibility of the designed interventions and determine the cost-effectiveness of such a 
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